Patents Assigned to Merck Patents GmbH
  • VISCOSITY REDUCTION OF HIGHLY CONCENTRATED PROTEIN FORMULATIONS
    Publication number: 20190314505
    Abstract: The present invention relates to compositions of highly concentrated protein formulations showing reduced viscosity.
    Type: Application
    Filed: April 16, 2019
    Publication date: October 17, 2019
    Applicant: Merck Patent GmbH
    Inventors: Martin ZILLMANN, Alexandra KROG, Raphael GUEBELI, Tanja HENZLER, Christian HILDEBRANDT
  • BISBENZOFURAN-FUSED 2,8-DIAMINOINDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED)
    Publication number: 20190315764
    Abstract: The present invention relates to bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds of formula (1) as materials for organic electroluminescent devices (OLEDs).
    Type: Application
    Filed: November 21, 2017
    Publication date: October 17, 2019
    Applicant: Merck Patent GmbH
    Inventors: Rouven Linge, Lara-Isabel Rodriguez, Sebastian Meyer, Holger Heil
  • Phenanthrene compounds for organic electronic devices
    Patent number: 10446759
    Abstract: The invention relates to specific phenanthrenes, the use of the compound in an electronic device, and an electronic device containing at least one of said compounds. The invention further relates to a method for producing the compound and a formulation and composition containing one or more of the compounds.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: October 15, 2019
    Assignee: Merck Patent GmbH
    Inventors: Teresa Mujica-Fernaud, Arne Buesing, Frank Voges, Jonas Kroeber
  • Mesogenic compounds, liquid crystal media and components for high frequency technology
    Patent number: 10442990
    Abstract: A liquid-crystal medium having a component A which is one or more compounds of the formula IA and corresponding, novel mesogenic compounds and the preparation thereof. These liquid-crystal media, are used in components for high-frequency technology, and to components of this type which contain the media. The components are suitable, in particular, for phase shifters in the microwave and millimeter wave region, for microwave and millimeter wave array antennae and very particularly for so-called tunable “reflectarrays”.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: October 15, 2019
    Assignee: Merck Patent GmbH
    Inventors: Christian Jasper, Elvira Montenegro, Detlef Pauluth, Volker Reiffenrath, Atsutaka Manabe
  • MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
    Publication number: 20190312203
    Abstract: The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices, which comprise these compounds.
    Type: Application
    Filed: May 31, 2017
    Publication date: October 10, 2019
    Applicant: Merck Patent GmbH
    Inventors: Rémi ANÉMAIN, Teresa MUJICA-FERNAUD, Myoung-Gi JO, Hyeon-Hui KANG, Jochen PFISTER
  • ELECTRONIC SWITCHING ELEMENT
    Publication number: 20190312216
    Abstract: An electronic switching element (1) which comprises, in this sequence, a first electrode (16), a molecular layer (18) bonded to a substrate, and a second electrode (20), where the molecular layer essentially consists of compounds of the formula I indicated in claim 1, in which a mesogenic radical is bonded to the substrate via a spacer group (Sp) by means of an anchor group (G), is suitable for the production of components (1) as memristive device for digital information storage.
    Type: Application
    Filed: July 4, 2017
    Publication date: October 10, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Peer KIRSCH, Andreas RUHL, Marc TORNOW, Achyut BORA
  • LIQUID CRYSTALLINE MEDIUM
    Publication number: 20190309225
    Abstract: The invention relates to dielectrically positive liquid crystalline media comprising a compound of formula I wherein R1 denotes alkenyl having 2 to 12 C atoms, and X1 denotes H, F or alkyl having 1 to 6 C atoms, and to liquid crystal displays comprising these media, especially to active matrix displays and in particular to TN, FFS and IPS mode displays.
    Type: Application
    Filed: December 6, 2017
    Publication date: October 10, 2019
    Applicant: Merck Patent GmbH
    Inventors: Michael WITTEK, Volker REIFFENRATH
  • DIRECTLY COMPRESSIBLE MATRIX FOR THE PRODUCTION OF TABLETS HAVING EXTENDED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
    Publication number: 20190307698
    Abstract: The present invention relates to tablets having extremely long release of active pharmaceutical ingredient, to the particular composition thereof and to the production thereof.
    Type: Application
    Filed: December 11, 2017
    Publication date: October 10, 2019
    Applicant: Merck Patent GmbH
    Inventors: Gudrun BIRK, Guenter MODDELMOG, Thorsten WEDEL
  • Particles for electrophoretic displays
    Patent number: 10435566
    Abstract: This invention relates to polymer particles preferably with surface functionality for charge retention, a process for their preparation, the use of these particles for the preparation of an electrophoretic device, electrophoretic displays comprising such particle, and new polymerizable dyes.
    Type: Grant
    Filed: November 27, 2015
    Date of Patent: October 8, 2019
    Assignee: Merck Patent GmbH
    Inventors: Louise Diane Farrand, Jonathan Henry Wilson, Mark James, Christopher Lutz, Nathan Smith, Mark John Goulding
  • Liquid crystalline medium
    Patent number: 10435626
    Abstract: The present invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy (??), which is distinguished by the fact that it has a value for the ratio ?1/?n2 in the range 6-45 with a clearing point of >60° C. and a ?? of ??2.3. Media of this type are particularly suitable for electro-optical displays having active-matrix addressing based on the ECB, PA LCD, FFS or IPS effect.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: October 8, 2019
    Assignee: Merck Patent GmbH
    Inventors: Melanie Klasen-Memmer, Sabine Schoen
  • Compounds for electronic devices
    Patent number: 10439145
    Abstract: The present invention relates to compounds which are suitable for use in electronic devices, preferably organic electroluminescent devices.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: October 8, 2019
    Assignee: Merck Patent GmbH
    Inventors: Holger Heil, Lara-Isabel Rodriguez, Fabrice Eckes, Oliver Kaufhold, Anja Gerhard, Stefan Riedmueller
  • Thiadiazolopyridine polymers, their synthesis and their use
    Patent number: 10435506
    Abstract: The present invention relates to thiadiazolopyridine polymers, their synthesis and their use. The present invention further relates to organic electronic devices comprising such thiadiazolopyridine polymers.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: October 8, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: William Mitchell, Mansoor D'Lavari
  • Polymerisable LC medium and polymer film with negative optical dispersion
    Patent number: 10435628
    Abstract: The invention relates to a polymerizable LC medium with negative optical dispersion, a polymer film with negative optical dispersion obtainable from such a medium, and the use of the polymerizable LC medium and polymer film in optical, electro optical, electronic, semiconducting or luminescent components or devices.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: October 8, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Joseph Sargent, Owain Llyr Parri, Kevin Adlem, Hassan Arasi
  • Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases
    Patent number: 10435472
    Abstract: The instant invention provides for a new method of treating bone metastasis diseases in subjects, wherein said method preferably depends on whether the subject shows certain specific proteins levels in one or more body fluids prior to or during treatment, wherein said treatment comprises the administration of at least one pan ?v integrin inhibitor to a subject, a medicament for use in said new methods, and a method of predicting the outcome of a treatment with at least one pan ?v integrin inhibitor based on said specific protein levels in one or more body fluids of the subject.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: October 8, 2019
    Assignee: Merck Patent GmbH
    Inventors: Josef Straub, Eike Staub
  • ANTI-ALCOHOL-INDUCED DOSE DUMPING TABLET BASED ON POLYVINYL ALCOHOL
    Publication number: 20190298655
    Abstract: The present invention relates to a directly shaped tablet from extrudate based on polyvinyl alcohol (PVA), which can be used for pharmaceutical products, and that due to its improved properties can be better easily shaped into tablets, which show anti-alcohol-induced dose dumping effect. Furthermore, this invention refers to pharmaceutical tablets composition comprising extruded polyvinyl alcohol as carrier matrix and can improve the solubility of API.
    Type: Application
    Filed: November 6, 2017
    Publication date: October 3, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Mengyao ZHENG, Alessandro ELIA
  • TRICYCLIC HETEROCYLIC DERIVATIVES
    Publication number: 20190300547
    Abstract: Compounds of the formula I in which R1 and R2 have the meanings indicated in Claim 1, are inhibitors of ATR, and can be employed for the treatment of diseases such as cancer.
    Type: Application
    Filed: May 22, 2017
    Publication date: October 3, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Lars BURGDORF, Dieter DORSCH, Christos TSAKLAKIDIS
  • ADDITIVES FOR LIQUID CRYSTAL MIXTURES
    Publication number: 20190300791
    Abstract: The invention relates to polyfluorinated additives for use as components in liquid-crystal mixtures, to liquid-crystal mixtures which comprise these compounds, and to liquid-crystal displays based on these mixtures.
    Type: Application
    Filed: December 5, 2017
    Publication date: October 3, 2019
    Applicant: MERCK PATENT GMBH
    Inventors: Peer KIRSCH, Qiong TONG, Helga HAAS, Kaja Christina DEING, Christoph MARTEN, Andreas POHLE, Reiner FRIEDRICH
  • Particles for electrophoretic displays
    Patent number: 10428220
    Abstract: This invention relates to polymer particles, a process for their preparation, the use of these particles for the preparation of an electrophoretic device, and electrophoretic displays comprising such particles.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: October 1, 2019
    Assignee: Merck Patent GmbH
    Inventors: Louise Diane Farrand, Claire Topping, Mark John Goulding
  • Piperidinyl derivatives
    Patent number: 10428024
    Abstract: Compounds of the formula I in which X, Y, R1 and R2 have the meanings indicated in Claim 1, are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: October 1, 2019
    Assignee: MERCK PATENT GMBH
    Inventor: Hans-Peter Buchstaller
  • TBK/IKK inhibitor compounds and uses thereof
    Patent number: 10428080
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKK? inhibitors.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: October 1, 2019
    Assignee: Merck Patent GmbH
    Inventors: Brian A. Sherer, Srinivasa Karra, Yufang Xiao